Hybrid 2024 - The challenges associated with future viral vectors and genome editing approaches
Автор: ariis
Загружено: 2024-02-22
Просмотров: 141
Next generations of gene & cell therapies
Session 1: The challenges associated with future viral vectors and genome editing approaches.
From the main challenges, avenues and prospects for new vectors to optimized delivery and safety, and tomorrow's genome-editing strategies.
Overview:
Oumeya Adjali, Inserm - Gene therapy using AAV viral vectors ; from vector engineering to preclinical evaluation
Short talks:
Ana Buj-Bello, Inserm - Next generation AAV vectors for gene therapy of muscle disorders
Alexis Duvergé, CNRS - Specific Targeting of Cancer Cells by Lentiviral Vectors
Maria Grazia Biferi, Spark Therapeutics - Targeting CNS with AAV in a large animal
Anarita Miccio, Inserm - Genome editing approaches for beta-hemoglobinopathies
Aurélie Bedel, Bordeaux University - How to secure CRISPR-Cas9 use?
Stéphane Boissel, Sparing Vision - Pioneering Genomics to Save Sight
Round table:
Sitra Tauscher-Wisniewski, Novartis
Anne Douar, Vivet Therapeutics
Annarita Miccio, Inserm
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
![[Conférence] H. CLEVERS - Lgr5 stem cells and Organoids](https://ricktube.ru/thumbnail/PwfNNKnzipQ/mqdefault.jpg)
![[EN] Conference - Daniel NOCERA - The Artificial Leaf - Académie des sciences](https://ricktube.ru/thumbnail/FSGQazr7W7c/mqdefault.jpg)
